(Reuters) - The biopharmaceutical company said it expected the job cuts to cost $600,000.
The company also said it appointed Chief Executive Laurence Birch as acting chief financial officer while the search for a new one continues. The company's chief financial officer, Ronald Pauli, resigned in March.
Read more at Reuters.com Market News
The company also said it appointed Chief Executive Laurence Birch as acting chief financial officer while the search for a new one continues. The company's chief financial officer, Ronald Pauli, resigned in March.
Read more at Reuters.com Market News
No comments:
Post a Comment